Due to some unique aspects of the EU Cosmetics Regulation compared to other EU product safety regulations, the cosmetics industry has been particularly impacted by Brexit. Given that Brexit has now taken place, it is timely to reconsider this ongoing impact on industry and provide some guidance on forward-looking planning.
On 18 February 2020, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), updated its guidance on medicine licensing post-Brexit “Apply for a licence to market a medicine in the UK”. The update provides further clarity on the UK’s status in the licensing process now that Brexit has taken place.
In January 2018, the UK’s Department for Business, Energy and Industrial Strategy (“BEIS”) provided its much-awaited response to proposals for reform to the product safety and product recall regimes.
On 9 January 2018, the UK introduced a ban on the manufacture or supply of products containing microbeads, following a worldwide trend towards greater oversight of plastic pollution. The ban will affect manufacturers of a wide range of cosmetics products, including face scrubs, toothpastes and shower gels.